LAUSR

[ ]this novel virus was called (SARS-CoV-2), and the WHO called it (Coronavirus disease) 2019 (COVID-19) [ ]March 21th 2020, there were about near reaching half a million established cases of COVID-19 in the world [4] Data Collection Characteristically of demographic;medicinal past;symptoms;medical symbols;workroom results;thoracic computed tomographic (CT) scan results were mined from automatic medicinal archives The CVA disease was (3 [5 7%] (2 of them with thromboembolic stroke and 1 with a hemorrhagic brain who pass on future from respiratory failure) vs 1 [0 8%) (1 ischemic stroke patient);reduced awareness (6 [14 80%] vs 2 [2 40%]) and muscular injury 8 (19 30%) vs 3 (4 8), P (0 001) About severe subgroup, patients with neurological manifestations also had lesser WBC, platelet totals and greater plasma urea nitrogen stages related with patients without CNS symptoms (lymphocyte): median, 0 70 [IQR, 0 10-1 60] vs 0 90 [IQR, 0 20-2 60], P<0 01;(platelet): median 169 00 IQR, 18 00-564 00] vs 220 00 [IQR, 109 0-576 0], P<0 05;(blood urea nitrogen)5 5 00[IQR, 2 30-48 10] vs 4 40 [IQR, 1 50-19 10] A very important point about the non-severe subgroup, not found important alterations in research laboratory results of patients with and without CNS symptoms